Outcome & informant | Control group | Treatment group | ||
---|---|---|---|---|
\( {\upalpha}_2^{\left(\mathrm{CG}\right)} \) | \( {\upalpha}_3^{\left(\mathrm{CG}\right)} \) | \( {\upalpha}_2^{\left(\mathrm{TG}\right)} \) | \( {\upalpha}_3^{\left(\mathrm{TG}\right)} \) | |
CAARS–O blinded clinician | ||||
 Inattention | −0.19* | − 0.19* | − 0.60* | − 0.19* |
 Hyperactivity | − 0.20* | − 0.20* | − 0.35* | − 0.35* |
 Impulsivity | − 0.25* | − 0.25* | − 0.62* | − 0.25* |
CAARS–S mother | ||||
 Inattention | −0.18* | − 0.18* | − 0.58* | − 0.18* |
 Hyperactivity | − 0.24* | − 0.24* | − 0.55* | − 0.24* |
 Impulsivity | − 0.23* | − 0.23* | − 0.62* | − 0.23* |